Personal information

No personal information available

Activities

Employment (4)

Novartis (Switzerland): Basel, CH

2024-01 to present | Postdoctoral Researcher (Analytical Research and Development)
Employment
Source: Self-asserted source
Olivia Luige

AstraZeneca R&D Gothenburg: Gothenburg, SE

2021-11 to 2023-12 | Senior Scientist (Separation Science Laboratory)
Employment
Source: Self-asserted source
Olivia Luige

Karolinska Institute: Stockholm, Stockholm, SE

2017-09 to 2021-11 | Doctoral student (Marie Curie Early Stage Researcher) (Organic and Bioorganic Chemistry)
Employment
Source: Self-asserted source
Olivia Luige

Link Technologies Limited: Glasgow, Scotland, GB

2015-07 to 2016-06 | Chemist (Royal Society of Chemistry-funded Industrial Placement)
Employment
Source: Self-asserted source
Olivia Luige

Education and qualifications (2)

Karolinska Institutet: Stockholm, Stockholm County, SE

2017 to 2022 | PhD Medical Science, Organic and Bioorganic Chemistry (Dept of Biosciences and Nutrition)
Education
Source: Self-asserted source
Olivia Luige

The University of Edinburgh: Edinburgh, Scotland, GB

2012 to 2017 | MChem Medicinal and Biological Chemistry (School of Chemistry)
Education
Source: Self-asserted source
Olivia Luige

Works (6)

Zinc N,N-bis(2-picolyl)amine Chelates Show Substitution-Dependent Cleavage of Phosphodiesters in Models as Well as of PNAzyme-RNA Bulges

Molecules
2024-05-03 | Journal article
Contributors: Søren W. Svenningsen; Olivia Luige; Zeyed Abdulkarim; Roger Strömberg; Nicholas H. Williams
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

An enhanced biophysical screening strategy to investigate the affinity of ASOs for their target RNA

RSC Chemical Biology
2023 | Journal article
Contributors: Rouven Stulz; Michael Lerche; Olivia Luige; Agnes Taylor; Stefan Geschwindner; Alice Ghidini
Source: check_circle
Crossref

Influence of sequence variation on the RNA cleavage activity of Zn2+-dimethyl-dppz-PNA-based artificial enzymes

RSC Advances
2022 | Journal article
Contributors: Olivia Luige; Kristina Karalė; Partha Pratim Bose; Martin Bollmark; Ulf Tedebark; Merita Murtola; Roger Strömberg
Source: check_circle
Crossref

Innovative developments and emerging technologies in RNA therapeutics

RNA Biology
2022-02-19 | Journal article
Part of ISSN: 1547-6286
Part of ISSN: 1555-8584
Source: Self-asserted source
Olivia Luige

Zn2+-Dependent peptide nucleic acid-based artificial ribonucleases with unprecedented efficiency and specificity

Chemical Communications
2021 | Journal article
Contributors: Olivia Luige; Partha Pratim Bose; Rouven Stulz; Peter Steunenberg; Omar Brun; Shalini Andersson; Merita Murtola; Roger Strömberg
Source: check_circle
Crossref

Further Probing of Cu2+-Dependent PNAzymes Acting as Artificial RNA Restriction Enzymes

Molecules
2019-02 | Journal article
Part of ISSN: 1420-3049
Contributors: Olivia Luige; Merita Murtola; Alice Ghidini; Roger Strömberg
Source: Self-asserted source
Olivia Luige via Crossref Metadata Search
grade
Preferred source (of 4)‎